Yang, Xin
Zhang, Linzixuan
MacDonald, Sydney https://orcid.org/0009-0006-4694-448X
Langer, Robert https://orcid.org/0000-0003-4255-0492
Jaklenec, Ana https://orcid.org/0000-0001-6096-0538
Article History
Received: 16 April 2025
Accepted: 20 November 2025
First Online: 6 December 2025
Competing interests
: From FY 2021 to the present, A.J. receives licensing fees (to patents on which she was an inventor) from, invested in, consults (or was on Scientific Advisory Boards or Boards of Directors) for, lectured (and received a fee), or conducts sponsored research at MIT for which she was not paid for the following entities: The Estée Lauder Companies; Moderna Therapeutics; OmniPulse Biosciences; Particles for Humanity; SiO 2 Materials Science; VitaKey. From FY 2021 to the present, R.L. receives licensing fees (to patents in which he was an inventor on) from, invested in, consults (or was on Scientific Advisory Boards or Boards of Directors) for, lectured (and received a fee), or conducts sponsored research at MIT for which he was not paid for the following entities: see . All other authors declare no competing interests.